Medicare Enrolled
Dr. Tauseef Syed, M.D.
Rheumatology · Greensboro, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Syed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Syed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Syed
Dr. Tauseef Syed is a rheumatology specialist in Greensboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Syed performed 3,413 Medicare services across 424 unique beneficiaries.
Between the years covered by Open Payments, Dr. Syed received a total of $14,334 from 63 pharmaceutical and/or device companies across 947 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Syed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 3,413 Medicare services
$14,334 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,413
Medicare services
Bottom 42% in NC for rheumatology
424
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~171 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,160 | $18 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
340 | $86 | $296 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
232 | $1 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
165 | $11 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
123 | $96 | $353 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
108 | $47 | $200 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $21 | $110 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
46 | $22 | $82 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $114 | $420 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
31 | $1 | $20 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
24 | $42 | $170 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
15 | $35 | $400 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
15 | $8 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $60 | $218 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
11 | $30 | $115 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.6% high complexity
73.0% medium
13.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,334
Total received (2018-2024)
Avg $2,048/year across 7 years
Top 21% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
947
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,033 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$301 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,246
2023
$2,420
2022
$2,400
2021
$2,526
2020
$1,683
2019
$1,486
2018
$1,573
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$370
Amgen Inc.
$347
UCB, Inc.
$298
Novartis Pharmaceuticals Corporation
$290
Mallinckrodt Hospital Products Inc.
$211
GlaxoSmithKline, LLC.
$155
Organon Llc
$114
Janssen Biotech, Inc.
$110
PFIZER INC.
$65
Fresenius Kabi USA, LLC
$53
AstraZeneca Pharmaceuticals LP
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
E.R. Squibb & Sons, L.L.C.
$29
Kiniksa Pharmaceuticals International, plc
$24
Sandoz Inc.
$22
Radius Health, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$18
iRhythm Technologies, Inc.
$15
Lilly USA, LLC
$15
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,089
UCB, Inc.
$1,615
AbbVie Inc.
$1,177
Novartis Pharmaceuticals Corporation
$1,158
PFIZER INC.
$870
ABBVIE INC.
$816
GlaxoSmithKline, LLC.
$730
Mallinckrodt Hospital Products Inc.
$711
Janssen Biotech, Inc.
$705
Lilly USA, LLC
$592
Genentech USA, Inc.
$401
AbbVie, Inc.
$303
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
Horizon Therapeutics plc
$179
E.R. Squibb & Sons, L.L.C.
$168
Horizon Pharma plc
$164
AstraZeneca Pharmaceuticals LP
$158
Janssen Scientific Affairs, LLC
$151
Amarin Pharma Inc.
$133
Daiichi Sankyo Inc.
$120
Organon Llc
$114
Eisai Inc.
$101
MannKind Corporation
$100
Bayer Healthcare Pharmaceuticals Inc.
$97
Esperion Therapeutics, Inc.
$97
Mannkind Corporation
$93
Novo Nordisk Inc
$77
Merck Sharp & Dohme Corporation
$77
Organon LLC
$71
Fresenius Kabi USA, LLC
$69
Bayer HealthCare Pharmaceuticals Inc.
$66
Astellas Pharma US Inc
$64
Biohaven Pharmaceuticals, Inc.
$59
Mallinckrodt Enterprises LLC
$59
SANOFI-AVENTIS U.S. LLC
$53
Radius Health, Inc.
$51
Xeris Pharmaceuticals, Inc.
$49
Medtronic, Inc.
$44
Janssen Pharmaceuticals, Inc
$42
Mallinckrodt LLC
$41
Takeda Pharmaceuticals U.S.A., Inc.
$38
Ultragenyx Pharmaceutical Inc.
$32
Dexcom, Inc.
$31
GENZYME CORPORATION
$27
Currax Pharmaceuticals LLC
$27
Clarus Therapeutics Inc.
$25
Kiniksa Pharmaceuticals International, plc
$24
Ironwood Pharmaceuticals, Inc
$24
Kiniksa Pharmaceuticals, Ltd.
$23
IBSA Pharma Inc.
$23
Sandoz Inc.
$22
Sobi, Inc
$18
IDORSIA PHARMACEUTICALS US INC
$18
Exeltis, USA Inc.
$17
LIFESCAN, INC.
$17
iRhythm Technologies, Inc.
$15
DePuy Synthes Sales Inc.
$14
Pharmacosmos Therapeutics Inc.
$13
MEDEXUS PHARMA, INC.
$12
Sunovion Pharmaceuticals Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
Actelion Pharmaceuticals US, Inc.
$9
United Therapeutics Corporation
$2
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · AMJEVITA · Actemra · Aimovig · Amitiza · Arcalyst · BASAGLAR · BELSOMRA · BENLYSTA · Bimzelx · CONTRAVE · COSENTYX · CYLTEZO · Cimzia · Crysvita · Cryvista · DUEXIS · DUZALLO · Dayvigo · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · Enbrel · Entyvio · FARXIGA · GVOKE HYPOPEN · GVOKE PFS · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · INFLECTRA · INJECTAFER · INTELLIS ADAPTIVESTIM · JANUVIA · JARDIANCE · JATENZO · KEVZARA · KRYSTEXXA · Kerendia · Kineret · LINZESS · Livalo · MONOVISC · MOUNJARO · MYRBETRIQ · Monoferric · NEXLETOL · NURTEC ODT · OFEV · ONETOUCH VERIO REFLECT · OPSUMIT · ORENCIA · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 13 · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · QUVIVIQ · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI ARIA · SKYRIZI · SOLIQUA 100/33 · STELARA · STIOLTO RESPIMAT · Saxenda · Synthroid · TALTZ · TAVNEOS · TOUJEO · TRADJENTA · TREMFYA · TRINTELLIX · TRULICITY · Tirosint · Tymlos · Utibron · Vascepa · XARELTO · XELJANZ · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
12
Per 100K population
2.2
County median income
$66,027
Nearest hospital
MOSES H. CONE MEMORIAL HOSPITAL, THE
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Syed is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Syed experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Syed performed 2,160 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Syed receive payments from pharmaceutical companies?
Yes. Dr. Syed received a total of $14,334 from 63 companies across 947 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Syed's costs compare to other rheumatologists in Greensboro?
Dr. Syed's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Syed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Greensboro
Browse rheumatologists in Greensboro ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology